Postepy Dermatologii I Alergologii : Impact Factor & More
eISSN: 2299-0046pISSN: 1642-395X
Open AccessShare this on:
Key Metrics
CiteScore 
2.1
Impact Factor
< 5
SJR
Q3Dermatology
SNIP
0.89
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Postepy Dermatologii I Alergologii
Postepy Dermatologii I Alergologii Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | TERMEDIA PUBLISHING HOUSE LTD |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | EUR 450 | PLN 2050 |
| Publication Time | 13 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Polish Society of Allergology |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Publication Time | 13 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in Postepy Dermatologii I Alergologii ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Postepy Dermatologii I Alergologii
Oral verrucous carcinoma in a 63-year-old male patient
- 1 Jan 2026
- Advances in Dermatology and Allergology
The role of the skin microbiome in modulating rosacea
- 1 Jan 2026
- Advances in Dermatology and Allergology
Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis
- 1 Jan 2026
- Advances in Dermatology and Allergology
Ibuprofen-induced multiple fixed drug eruption in a 3-year-old child confirmed by patch testing
- 1 Jan 2026
- Advances in Dermatology and Allergology
Omalizumab in the management of bullous pemphigoid: a six-month retrospective study
- 1 Jan 2026
- Advances in Dermatology and Allergology
Pyoderma gangrenosum following joint arthroplasty: a comprehensive review of clinical features, diagnosis, and management
- 1 Jan 2026
- Advances in Dermatology and Allergology
Oral verrucous carcinoma in a 63-year-old male patient
- 1 Jan 2026
- Advances in Dermatology and Allergology
The role of the skin microbiome in modulating rosacea
- 1 Jan 2026
- Advances in Dermatology and Allergology
Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis
- 1 Jan 2026
- Advances in Dermatology and Allergology
Ibuprofen-induced multiple fixed drug eruption in a 3-year-old child confirmed by patch testing
- 1 Jan 2026
- Advances in Dermatology and Allergology
Omalizumab in the management of bullous pemphigoid: a six-month retrospective study
- 1 Jan 2026
- Advances in Dermatology and Allergology
Pyoderma gangrenosum following joint arthroplasty: a comprehensive review of clinical features, diagnosis, and management
- 1 Jan 2026
- Advances in Dermatology and Allergology
FAQs on Postepy Dermatologii I Alergologii
How long has Postepy Dermatologii I Alergologii been actively publishing? 
What is the publishing frequency of Postepy Dermatologii I Alergologii?
How many articles did Postepy Dermatologii I Alergologii publish last year?
What is the eISSN & pISSN for Postepy Dermatologii I Alergologii?
What is Citescore for Postepy Dermatologii I Alergologii?
What is SNIP score for Postepy Dermatologii I Alergologii?
What is the SJR for Postepy Dermatologii I Alergologii?
Who is the publisher of Postepy Dermatologii I Alergologii?
